News

Dexcom Goes Pro With Latest Nod for CGM System

The San Diego-based company continues to shape its CGM portfolio as it faces off against some stiff competition in the market.

A Blood Filter Fights Deadly Inflammatory Response

The CytoSorb blood purification device helps stabilize the conditions of critically ill or injured patients by removing a storm of inflammatory toxins from the blood.

Medtronic and Axonics Go Toe-to-Toe in Fast-Growing Sacral Neuromodulation Market

Medtronic dropped a big announcement this week related to its InterStim Micro Neurostimulator almost exactly a month after Axonics won FDA approval for the first rechargeable sacral neuromodulation device.

Qiagen and Illumina in It for the Long Haul with 15-year Collaboration

The two firms want to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics. The news comes as Qiagen’s CEO Peer Schatz announced he is stepping down.

Aethlon Takes Big Steps in Oncology with New IDE

The San Diego-based company said it was granted an IDE to initiate an early feasibility study of the Hemopurifier in patients with head and neck cancer in combination with standard of care pembrolizumab (KeyTruda).

Hardware Sprinting Without Trade-Offs

In an interview with MD+DI, Addifab’s U.S. CEO Carsten Jarfelt spoke about the company's Freeform Injection Molding (FIM), a new technology that marries 3-D printing with traditional injection molding. He will explore the benefits of FIM during a presentation at MD&M Minneapolis.

Zimmer Biomet Strikes Out at the US Supreme Court Over Hefty Infringement Award

Zimmer Biomet was found in 2017 to have willfully infringed Stryker's patent which led to a tripling of a $70 million damage award against it. The judgment was one of the largest ever awarded for enhanced patent damages.

Forest Devices Is Crushing It This Year

A startup developing the first portable stroke screening device won the MedTech Innovator 2019 Showcase at The MedTech Conference in Boston, MA.

New Breath Test Detects Opioid Use

A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians at the University of California, Davis. A breath test could be useful in caring for chronic pain patients as well as for checking for illegal drug use.

Guideline Inclusion Could Open More Doors for WATS3D

The American Society for Gastrointestinal Endoscopy has included CDx Diagnostics’ WATS3D diagnostic platform in a new practice Guideline for the screening and surveillance of Barrett’s esophagus.

What If a Machine Could Read Your Brain Signals for Pain?

Researchers develop a system that could help with diagnosing and treating pain in unconscious or noncommunicative patients.

Investors’ Faith in Endotronix Continues with Expanded D Round

The Lisle, IL-based company initially brought in $45 million in a series D round last year – but expanded the financing and raised an additional $35 million. Endotronix will use proceeds from the round for a more robust clinical trial to nab FDA approval and National Coverage Determination for the Cordella Pulmonary Artery Sensor.

AngioDynamics Has Laser Focus on PAD with New Acquisition

The Latham, NY-based company is set to acquire Eximo Medical for about $46 million in up-front consideration with the possibility of up to $20 million in milestones. Eximo’s laser technology has been cleared by FDA for use in the treatment of Peripheral Artery Disease.

This Is How Americans Feel About Manufacturing in 2019

How do Americans feel about the manufacturing sector? A new survey from product sourcing, supplier selection, and marketing solutions company Thomas polled participants from across the US to take a temperature on how Americans feel about manufacturing both from an economic standpoint and as a...

Lantheus Takes a Dive into Pharma with Proposed Acquisition

The North Billerica, MA-based company is set to acquire Progenics Pharmaceuticals, an oncology firm developing innovative medicines and artificial intelligence to find, fight and follow cancer. It is an all-stock transaction set to close in 1Q20.

Qmed Search Form